Suzuken Co., Ltd.

Tokyo Stock Exchange 9987.T

Suzuken Co., Ltd. Return on Assets (ROA) for the year ending March 31, 2024: 2.36%

Suzuken Co., Ltd. Return on Assets (ROA) is 2.36% for the year ending March 31, 2024, a 33.03% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Suzuken Co., Ltd. Return on Assets (ROA) for the year ending March 31, 2023 was 1.78%, a 40.81% change year over year.
Suzuken Co., Ltd. Return on Assets (ROA) for the year ending March 31, 2022 was 1.26%, a 77.95% change year over year.
Suzuken Co., Ltd. Return on Assets (ROA) for the year ending March 31, 2021 was 0.71%, a -72.06% change year over year.
Suzuken Co., Ltd. Return on Assets (ROA) for the year ending March 31, 2020 was 2.54%, a -0.15% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Tokyo Stock Exchange: 9987.T

Suzuken Co., Ltd.

CEO	Mr. Shigeru Asano
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	8 Higashi Kataha-machi
Employees	13,086
Sector	Healthcare
Industries Pharmaceuticals Automotive Parts Cleaning Supplies Drugstores & Retail Pharmacies Hardware & Electronics Non-Alcoholic Beverages Personal Care

Description

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Key trends

Past 5 years